Long-term variations of atmospheric wave activity in the mesosphere and lower thermosphere region over the equatorial Pacific

Autor: Tsuda, T ^*, Yoshida, S, Isoda, F, Nakamura, T, Nuryanto, A, Manurung, S, Sobari, O, Vincent, R.A, Reid, I.M

Publikováno v: In Journal of Atmospheric and Solar-Terrestrial Physics 2002 64(8):1123-1129

A Study on the Predawn Ionospheric Heating Effect and Its Main Controlling Factors.

Autor: Tang, Zhenzhang^1,2,3 (AUTHOR) tangzhenzhang22@mails.ucas.ac.cn, Le, Huijun^1,2,3,4 (AUTHOR) lehj@mail.iggcas.ac.cn, Liu, Libo^1,2,3,4 (AUTHOR) chenyd@mail.iggcas.ac.cn, Chen, Yiding^1,2,3,5 (AUTHOR) zhangruilong@mail.iggcas.ac.cn, Zhang, Ruilong^1,2,3,4 (AUTHOR) llwwb@mail.iggcas.ac.cn, Li, Wenbo^1,4 (AUTHOR) lwdong@mail.iggcas.ac.cn, Liu, Wendong^1,2,3 (AUTHOR)

Publikováno v: Remote Sensing. Oct2024, Vol. 16 Issue 20, p3809. 11p.

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations.

Autor: Iiizumi S; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. iizumi_s@brightpathbio.com.; Research & Early Development Division, BrightPath Biotherapeutics Co., Ltd., 3-25-22 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. iizumi_s@brightpathbio.com., Ohtake J; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. qsl.suivx2000@gmail.com., Murakami N; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. n.murakami_0131v2@outlook.jp.; Research & Early Development Division, BrightPath Biotherapeutics Co., Ltd., 3-25-22 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. n.murakami_0131v2@outlook.jp., Kouro T; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. kourot@gancen.asahi.yokohama.jp., Kawahara M; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. mmrkawahara@gancen.asahi.yokohama.jp., Isoda F; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. isoda_f@brightpathbio.com.; Research & Early Development Division, BrightPath Biotherapeutics Co., Ltd., 3-25-22 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. isoda_f@brightpathbio.com., Hamana H; Department of Innovative Cancer Immunotherapy, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. hamana@med.u-toyama.ac.jp., Kishi H; Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. immkishi@med.u-toyama.ac.jp., Nakamura N; Research & Early Development Division, BrightPath Biotherapeutics Co., Ltd., 3-25-22 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan. nakamura_n@brightpathbio.com., Sasada T; Department of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan. tsasada@kcch.jp.

Publikováno v: Cancers [Cancers (Basel)] 2019 Feb 24; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 24.

Inflammation and aging-related disease: A transdisciplinary inflammaging framework.

Autor: Andonian BJ; Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC, USA. brian.andonian@duke.edu., Hippensteel JA; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Abuabara K; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA., Boyle EM; Department of Haematology, University College London Cancer Institute, London, UK., Colbert JF; Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Devinney MJ; Division of Critical Care, Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA., Faye AS; Division of Gastroenterology, Department of Population Health, NYU Langone Medical Center, New York, NY, USA., Kochar B; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Lee J; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Litke R; Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nair D; Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA., Sattui SE; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Sheshadri A; Division of Nephrology, Department of Medicine, University of California, San Francisco, Nephrology Section, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA., Sherman AN; American Federation for Aging Research, New York, NY, USA., Singh N; Division of Rheumatology, University of Washington, Seattle, WA, USA., Zhang Y; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., LaHue SC; Department of Neurology, School of Medicine, and the UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Publikováno v: GeroScience [Geroscience] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.

T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective.

Autor: Tanaka, S.-I., Isoda, F., Ishihara, Y., Kimura, M., Yamakawa, T.

Publikováno v: Clinical Endocrinology; Mar2001, Vol. 54 Issue 3, p347-354, 08p